Selective Targeting of Adjuvant Therapy for Endometrial Cancer: The STATEC Trial [ 2015 - 2021 ]

Research Grant

Researchers: A/Pr Alison Brand (Principal investigator) ,  A/Pr Linda Mileshkin ,  Dr Julie Martyn ,  Dr Pearly Khaw ,  Prof Andreas Obermair
View all 8 related researchers

Brief description This international collaborative trial for women with aggressive endometrial cancer will investigate whether lymph node removal (lymphadenectomy) at time of hysterectomy is needed to predict whether patients need additional treatment, compared to not removing the lymph nodes and giving additional treatment to all such patients. If we can select patients who need further treatment more accurately, we will avoid giving patients unnecessary toxic treatment which impacts on their quality of life.

Funding Amount $AUD 1,239,309.81

Funding Scheme Project Grants

Notes Standard Project Grant